The countries of the European Economic Community have recently mounted considerable efforts to commercialize biotechnology. Together, these efforts approach the same number of companies and level of government spending as those in the United States. In Europe there is more government emphasis on support for industry-university collaborations and industrial projects than in the United States, where basic research is emphasized. European efforts are often not easily delineated from those in the United States; many European companies have extensive U.S. operations and many U.S. companies have involvement in Europe. Strategies and efforts in European biotechnology are examined and compared to those in the United States.